Target group: Everyone with an interest in science although young scientists are preferably welcomed for a great opportunity to meet distinguished speakers and discuss scientific, but also career questions, during the training school Q&A sessions.
Participation fee: free of charge
Registration deadline: November 8th 2022
This autumn school receives funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 823893 (EU-OPENSCREEN-DRIVE).
Starting with a general introduction to the field, we will continue by exploring more specific subjects such as
In this year's EU-OPENSCREEN Autumns School also representatives from the industrial sector will share their knowledge and expertise on the latest advances in HTS and test development.
Welcome and Introduction9:30 - 10:30 | EU-OPENSCREEN ERIC Screening and Medicinal Chemistry ServicesWolfgang FeckeDirector General EU-OPENSCREEN ERIC, Coordinator EU-OPENSCREEN-DRIVE, Germany |
10:30 - 11:30 | Strategies on medicinal chemistry: Drug discovery and developmentAna MartinezCentro de Investigaciones Biológicas Margarita Salas (CSIC), Spain |
11:30 | Break (15') |
11:45 - 12:45 | Making data FAIR - a great way to increase the impact of your researchPhil GribbonHead of Hamburg Location, Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg |
12:45 | Lunch Break (75') |
14:00 - 15:00 | Hit SelectionJohannes LandskronNorwegian Center for Molecular Medicine (NCMM) at Oslo University (UiO), Norway |
09:30 - 10:30 | Introduction to CheminformaticsDaniel SvozilInstitute of Molecular Genetics of the Czech Academy of Sciences (IMG), Czech Republic |
10:30 - 11:30 | The European Chemical Biology Database (ECBD)Tomas MullerInstitute of Molecular Genetics of the Czech Academy of Sciences (IMG), Czech Republic |
11:30 | Break (15') |
11:45 - 12:45 | Assay Development and Compound Profiling in Drug DiscoveryThomas LundbäckSenior Director, Mechanistic & Structural Biology, Discovery Sciences, R&D, AstraZeneca, Sweden |
12:45 | Lunch Break (75') |
14:00 - 15:00 | High throughput screening with natural products librariesOlga GenilloudScientific Director Fundación MEDINA, Spain |
09:30 - 10:30 | Designing chemical probes for serine hydrolasesRui MoreiraPresident of the European Federation for Medicinal Chemistry (EFMC), Research Institute for Medicine (imed), Portugal |
10:30 - 11:30 | Assay development and optimizationPepo BreaUniversity of Santiago de Compostela (USC), Spain |
11:30 | Break (15') |
11:45 - 12:45 | Chemical proteomicsGuillaume MédardTUM School of Life Sciences, Technical University of Munich, Germany |
12:45 | Lunch Break (75') |
14:00 - 15:00 | Quantifying Target Engagement in Cells with NanoBRET probesMatthew RobersPromega Corporation |
09:30 - 10:30 | Introduction to the translational development pipeline – from idea to the patientRebecca Ludwig, Alicia SolerEATRIS | European infrastructure for translational medicine |
10:30 - 11:30 | Mechanism of Action and Target Identification StudiesBrinton Seashore-LudlowChemical Biology Consortium Sweden (CBCS) |
11:30 | Break (15') |
11:45 - 12:45 | A toolkit towards the design of antimetastatic advanced therapiesMaria J. VicentCentro de Investigación príncipe Felipe, Spain |
12:45 | Lunch Break (75') |
14:00 - 15:00 | Drug sensitivity and resistance testingJani SaarelaInstitute for Molecular Medicine Finland (FIMM) |
1st Session09:30 - 10:30 | Optimizing the biological profile of compounds in the drug discovery processSheraz GulFraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Germany |
10:30 - 11:30 | General introduction to chemical biologyMabel Loza, Maria Joao MatosUniversity of Santiago de Compostela (USC), Spain |
11:30 | Break (15') |
11:45 - 12:45 | Screening automationMartin NeuenschwanderLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Germany |
12:45 | Lunch Break (75') |
14:00 - 15:00 | Using QC purity + identity assessment to enhance data reproducibility and reliabilityFederica RossellaEU-OPENSCREEN ERIC, Germany |